Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Kudrycki

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Pharmacology|July 17, 2024
Life scientists improve QSP model quality and impactKatherine Kudrycki, Christina Friedrich, Mike Reed, et al.
Plos One|June 17, 2020
Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor levelRonald B Moss, Meghan McCabe Pryor, Rebecca Baillie, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 25, 2022
Quantitative systems pharmacology model of the amyloid pathway in Alzheimer's disease: Insights into the therapeutic mechanisms of clinical candidatesVidya Ramakrishnan, Christina Friedrich, Colleen Witt, et al.
Gene Regulation and Systems Biology|August 15, 2017
A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque CharacteristicsJeffrey E Ming, Ruth E Abrams, Derek W Bartlett, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|July 17, 2024
Life scientists improve QSP model quality and impactKatherine Kudrycki, Christina Friedrich, Mike Reed, et al.
Plos One|June 17, 2020
Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor levelRonald B Moss, Meghan McCabe Pryor, Rebecca Baillie, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 25, 2022
Quantitative systems pharmacology model of the amyloid pathway in Alzheimer's disease: Insights into the therapeutic mechanisms of clinical candidatesVidya Ramakrishnan, Christina Friedrich, Colleen Witt, et al.
Gene Regulation and Systems Biology|August 15, 2017
A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque CharacteristicsJeffrey E Ming, Ruth E Abrams, Derek W Bartlett, et al.
Pageof 1